{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T18:11:13Z","timestamp":1783188673631,"version":"3.54.6"},"reference-count":38,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2010,4,20]],"date-time":"2010-04-20T00:00:00Z","timestamp":1271721600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["obgyn.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BJOG"],"published-print":{"date-parts":[[2010,6]]},"abstract":"<jats:p> <jats:italic>Please cite this paper as<\/jats:italic>: Durocher J, Bynum J, Le\u00f3n W, Barrera G, Winikoff B. High fever following postpartum administration of sublingual misoprostol. BJOG 2010;117:845\u2013852.<\/jats:p><jats:p><jats:bold>Objective\u2002<\/jats:bold> To explore what triggers an elevated body temperature of \u226540.0\u00b0C in some women given misoprostol, a prostaglandin E1 analogue, for postpartum haemorrhage (PPH).<\/jats:p><jats:p><jats:bold>Design\u2002<\/jats:bold>  <jats:italic>Post hoc<\/jats:italic> analysis.<\/jats:p><jats:p><jats:bold>Setting\u2002<\/jats:bold> One tertiary\u2010level hospital in Quito, Ecuador.<\/jats:p><jats:p><jats:bold>Population\u2002<\/jats:bold> A cohort of 58 women with a fever of above 40\u00b0C following treatment with sublingual misoprostol (800\u2003micrograms) for PPH.<\/jats:p><jats:p><jats:bold>Methods\u2002<\/jats:bold> Side effects were documented for 163 Ecuadorian women given sublingual misoprostol to treat their PPH. Women\u2019s body temperatures were measured, and if they had a fever of \u226540.0\u00b0C, measurements were taken hourly until the fever subsided. Temperature trends were analysed, and the possible physiological mechanisms by which postpartum misoprostol produces a high fever were explored.<\/jats:p><jats:p><jats:bold>Main outcome measures\u2002<\/jats:bold> The onset, duration, peak temperatures, and treatments administered for cases with a high fever.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> Fifty\u2010eight of 163 women (35.6%) treated with misoprostol experienced a fever of \u226540.0\u00b0C. High fevers followed a predictable pattern, often preceded by moderate\/severe shivering within 20\u2003minutes of treatment. Body temperatures peaked 1\u20132\u2003hours post\u2010treatment, and gradually declined over 3\u2003hours. Fevers were transient and did not lead to any hospitalisation. Baseline characteristics were comparable among women who did and did not develop a high fever, except for known previous PPH and time to placental expulsion.<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold> An unexpectedly high rate of elevated body temperature of \u226540.0\u00b0C was documented in Ecuador following sublingually administered misoprostol. It is unclear why temperatures \u226540.0\u00b0C occurred with a greater frequency in Ecuador than in other study populations using similar treatment regimens for PPH. Pharmacogenetic studies may shed further light on variations in individuals\u2019 responses to misoprostol.<\/jats:p>","DOI":"10.1111\/j.1471-0528.2010.02564.x","type":"journal-article","created":{"date-parts":[[2010,4,29]],"date-time":"2010-04-29T11:00:46Z","timestamp":1272538846000},"page":"845-852","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["High fever following postpartum administration of sublingual misoprostol"],"prefix":"10.1111","volume":"117","author":[{"given":"J","family":"Durocher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Bynum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Le\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Barrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Winikoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,5,10]]},"reference":[{"key":"e_1_2_10_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000494.pub3"},{"key":"e_1_2_10_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003249.pub2"},{"key":"e_1_2_10_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpobgyn.2008.08.005"},{"key":"e_1_2_10_5_2","volume-title":"WHO statement regarding the use of misoprostol for postpartum haemorrhage prevention and treatment","author":"WHO Department of Reproductive Health and Research","year":"2009"},{"key":"e_1_2_10_6_2","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.08.055715"},{"key":"e_1_2_10_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1999.tb08266.x"},{"key":"e_1_2_10_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0029-7844(03)00174-1"},{"key":"e_1_2_10_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0029-7844(97)00111-7"},{"key":"e_1_2_10_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/17.2.332"},{"key":"e_1_2_10_11_2","doi-asserted-by":"publisher","DOI":"10.1080\/14767050802452309"},{"key":"e_1_2_10_12_2","first-page":"432","article-title":"Side\u2013effects of oral misoprostol in the third stage of labour\u2014a randomised placebo\u2013controlled trial","volume":"91","author":"Hofmeyr GJ","year":"2001","journal-title":"S Afr Med J"},{"key":"e_1_2_10_13_2","unstructured":"G\u00fclmezogluAM VillarJ NgocNTN PiaggioG CarroliG AdetoroL et\u00a0al.WHO multicentre randomised trial of misoprostol in the management of the third stage of labour."},{"key":"e_1_2_10_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/16.1.31"},{"key":"e_1_2_10_15_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-0528.2002.t01-1-02019.x"},{"key":"e_1_2_10_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0029-7844(97)00275-5"},{"key":"e_1_2_10_17_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2393-4-16"},{"key":"e_1_2_10_18_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2393-8-40"},{"key":"e_1_2_10_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61923-1"},{"key":"e_1_2_10_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61924-3"},{"key":"e_1_2_10_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-7634(05)80009-0"},{"key":"e_1_2_10_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000441-198710000-00011"},{"key":"e_1_2_10_23_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.158.17.1870"},{"key":"e_1_2_10_24_2","unstructured":"Personal communication with Eric Schaff on November 3 2009 regarding data points on pharmacokinetics of sublingual misoprostol."},{"key":"e_1_2_10_25_2","first-page":"145","article-title":"The neurobiology of the human febrile response: update for nurse anesthetists","volume":"74","author":"Biddle C","year":"2006","journal-title":"AANA J"},{"key":"e_1_2_10_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbpa.2006.06.032"},{"key":"e_1_2_10_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.200500207"},{"key":"e_1_2_10_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4522(97)00448-X"},{"key":"e_1_2_10_29_2","doi-asserted-by":"publisher","DOI":"10.1097\/00003081-200009000-00006"},{"key":"e_1_2_10_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1998.tb10259.x"},{"key":"e_1_2_10_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2006.02.013"},{"key":"e_1_2_10_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60914-3"},{"key":"e_1_2_10_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jri.2008.04.002"},{"key":"e_1_2_10_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1997.tb11464.x"},{"key":"e_1_2_10_35_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajpa.1330320310"},{"key":"e_1_2_10_36_2","doi-asserted-by":"publisher","DOI":"10.1159\/000095498"},{"key":"e_1_2_10_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijgo.2009.11.006"},{"key":"e_1_2_10_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmwh.2008.09.010"},{"key":"e_1_2_10_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2003.10.004"}],"container-title":["BJOG: An International Journal of Obstetrics &amp; Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1471-0528.2010.02564.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1471-0528.2010.02564.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T14:45:27Z","timestamp":1698763527000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1111\/j.1471-0528.2010.02564.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,10]]},"references-count":38,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["10.1111\/j.1471-0528.2010.02564.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1471-0528.2010.02564.x","archive":["Portico"],"relation":{},"ISSN":["1470-0328","1471-0528"],"issn-type":[{"value":"1470-0328","type":"print"},{"value":"1471-0528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,10]]},"assertion":[{"value":"2010-05-10","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}